Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)
Condition(s):Autoimmune Bullous Dermatosis; Glucocorticoids ToxicityLast Updated:August 31, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Autoimmune Bullous Dermatosis; Glucocorticoids ToxicityLast Updated:August 31, 2023Active, not recruiting
Condition(s):Chronic Rhinosinusitis With Nasal Polyps; GlucocorticoidsLast Updated:March 10, 2023Recruiting
Condition(s):Adrenal; Insufficiency Gluccorticoid-Induced; Cushing; Syndrome or Disease, Glucocorticoid-InducedLast Updated:July 2, 2018Completed
Condition(s):Chronic Rhinosinusitis With Nasal Polyps; GlucocorticoidsLast Updated:October 28, 2022Not yet recruiting
Condition(s):Rheumatoid ArthritisLast Updated:May 18, 2020Completed
Condition(s):Thyroid Associated OphthalmopathyLast Updated:May 18, 2021Unknown status
Condition(s):HypertensionLast Updated:November 30, 2018Completed
Condition(s):Osteoporosis; Inflammatory RheumatismLast Updated:September 5, 2023Recruiting
Condition(s):Knee OsteoarthritisLast Updated:March 10, 2023Not yet recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:August 4, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.